The biotechnology story is one that continues to highlight evolving growth opportunities in the medical field. More
Short sellers are making fools' bets against biotech stocks, which are looking stronger than the broader market. Investors should target MYGN, THRX, GHDX ... and even the whole sector via XBI. More
These five ETFs to buy now all fit together very nicely to form a good foundation for your portfolio -- and individually, these five funds all offer a lot of upside potential regardless of your investment goals.
The XBI biotech ETF is your best way to tap into the growth of healthcare and the stability of a good, cheap exchange traded fund. More
Discovery why biotech stocks are unlikely candidates for blowout performance in 2015. More
If you want to beat the market, check out these five best ETFs across several different investment flavors. More
Merck's buyout of Idenix didn't just pump up IDIX shares -- it also had a great double effect on biotech ETFs such as XBI that usually are buoyed by M&A. More
Advertise With Us
Terms and Conditions
Disclosures and Disclaimers
More On InvestorPlace:
Financial Market Data powered by FinancialContent Services, Inc. All rights reserved. Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Copyright ©2015 InvestorPlace Media, LLC. All rights reserved. 700 Indian Springs Drive, Lancaster, PA 17601.